Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study.
Basile D, Gerratana L, Corvaja C, Pelizzari G, Franceschin G, Bertoli E, Palmero L, Zara D, Alberti M, Buriolla S, Da Ros L, Bonotto M, Mansutti M, Spazzapan S, Cinausero M, Minisini AM, Fasola G, Puglisi F. Basile D, et al. Among authors: alberti m. Breast. 2021 Jun;57:104-112. doi: 10.1016/j.breast.2021.02.015. Epub 2021 Mar 12. Breast. 2021. PMID: 33812267 Free PMC article.
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
Poetto AS, Posocco B, Gagno S, Orleni M, Zanchetta M, Iacuzzi V, Canil G, Buzzo M, Montico M, Guardascione M, Basile D, Pelizzari G, Alberti M, Gerratana L, Puglisi F, Toffoli G. Poetto AS, et al. Among authors: alberti m. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Nov 15;1185:122985. doi: 10.1016/j.jchromb.2021.122985. Epub 2021 Oct 11. J Chromatogr B Analyt Technol Biomed Life Sci. 2021. PMID: 34700133
Immunotherapy in NSCLC Patients with Brain Metastases.
Buriolla S, Pelizzari G, Corvaja C, Alberti M, Targato G, Bortolot M, Torresan S, Cortiula F, Fasola G, Follador A. Buriolla S, et al. Among authors: alberti m. Int J Mol Sci. 2022 Jun 25;23(13):7068. doi: 10.3390/ijms23137068. Int J Mol Sci. 2022. PMID: 35806080 Free PMC article. Review.
"A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring".
Soledad Poetto A, Posocco B, Zanchetta M, Gagno S, Orleni M, Canil G, Alberti M, Puglisi F, Toffoli G. Soledad Poetto A, et al. Among authors: alberti m. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Sep 1;1207:123403. doi: 10.1016/j.jchromb.2022.123403. Epub 2022 Aug 2. J Chromatogr B Analyt Technol Biomed Life Sci. 2022. PMID: 35940043
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer.
Roncato R, Gerratana L, Palmero L, Gagno S, Poetto AS, Peruzzi E, Zanchetta M, Posocco B, De Mattia E, Canil G, Alberti M, Orleni M, Toffoli G, Puglisi F, Cecchin E. Roncato R, et al. Among authors: alberti m. Front Pharmacol. 2022 Jul 22;13:897951. doi: 10.3389/fphar.2022.897951. eCollection 2022. Front Pharmacol. 2022. PMID: 35942220 Free PMC article.
Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives.
de Scordilli M, Michelotti A, Zara D, Palmero L, Alberti M, Noto C, Totaro F, Foltran L, Guardascione M, Iacono D, Ongaro E, Fasola G, Puglisi F. de Scordilli M, et al. Among authors: alberti m. Crit Rev Oncol Hematol. 2023 Jun;186:104013. doi: 10.1016/j.critrevonc.2023.104013. Epub 2023 Apr 26. Crit Rev Oncol Hematol. 2023. PMID: 37116817 Review.
MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence.
Bousquet J, Arnavielhe S, Bedbrook A, Bewick M, Laune D, Mathieu-Dupas E, Murray R, Onorato GL, Pépin JL, Picard R, Portejoie F, Costa E, Fonseca J, Lourenço O, Morais-Almeida M, Todo-Bom A, Cruz AA, da Silva J, Serpa FS, Illario M, Menditto E, Cecchi L, Monti R, Napoli L, Ventura MT, De Feo G, Larenas-Linnemann D, Fuentes Perez M, Huerta Villabolos YR, Rivero-Yeverino D, Rodriguez-Zagal E, Amat F, Annesi-Maesano I, Bosse I, Demoly P, Devillier P, Fontaine JF, Just J, Kuna TP, Samolinski B, Valiulis A, Emuzyte R, Kvedariene V, Ryan D, Sheikh A, Schmidt-Grendelmeier P, Klimek L, Pfaar O, Bergmann KC, Mösges R, Zuberbier T, Roller-Wirnsberger RE, Tomazic P, Fokkens WJ, Chavannes NH, Reitsma S, Anto JM, Cardona V, Dedeu T, Mullol J, Haahtela T, Salimäki J, Toppila-Salmi S, Valovirta E, Gemicioğlu B, Yorgancioglu A, Papadopoulos N, Prokopakis EP, Bosnic-Anticevich S, O'Hehir R, Ivancevich JC, Neffen H, Zernotti E, Kull I, Melen E, Wickman M, Bachert C, Hellings P, Palkonen S, Bindslev-Jensen C, Eller E, Waserman S, Sova M, De Vries G, van Eerd M, Agache I, Casale T, Dykewickz M, Naclerio RN, Okamoto Y, Wallace DV; MASK study group. Bousquet J, et al. Clin Transl Allergy. 2018 Oct 25;8:45. doi: 10.1186/s13601-018-0227-6. eCollection 2018. Clin Transl Allergy. 2018. PMID: 30386555 Free PMC article. Review.
361 results